NCT00397176View on ClinicalTrials.gov

Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

February 28, 2007

Conditions
Vasomotor Symptoms
Interventions
DRUG

desvenlafaxine succinate sustained release (DVS SR)

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00397176 - Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women | Biotech Hunter | Biotech Hunter